The estimated Net Worth of Leonard Sank is at least $90.4 Mille dollars as of 8 August 2022. Mr. Sank owns over 20,000 units of Oramed Pharmaceuticals, Inc stock worth over $90,440 and over the last 17 years he sold ORMP stock worth over $0. In addition, he makes $0 as Independent Director at Oramed Pharmaceuticals, Inc.
Leonard has made over 10 trades of the Oramed Pharmaceuticals, Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of ORMP stock worth $81,600 on 8 August 2022.
The largest trade he's ever made was buying 216,160 units of Oramed Pharmaceuticals, Inc stock on 31 December 2007 worth over $58,363. On average, Leonard trades about 17,990 units every 222 days since 2007. As of 8 August 2022 he still owns at least 38,000 units of Oramed Pharmaceuticals, Inc stock.
You can see the complete history of Mr. Sank stock trades at the bottom of the page.
Leonard Sank serves as Independent Director of the Company. Mr. Sank is a South African entrepreneur and businessman, whose interests lie in entrepreneurial endeavors and initiatives, with over 20 years’ experience of playing significant leadership roles in developing businesses. For the past nineteen years, Mr. Sank has served on the boards of a few national businesses and local non-profit charity organizations in Cape Town, where he resides.
Leonard Sank is 55, he's been the Independent Director of Oramed Pharmaceuticals, Inc since 2008. There are 7 older and 7 younger executives at Oramed Pharmaceuticals, Inc. The oldest executive at Oramed Pharmaceuticals, Inc is Dr. Miriam Kidron Ph.D., 81, who is the Chief Scientific Officer & Director.
Leonard's mailing address filed with the SEC is 3 BLAIR ROAD, , CAPE TOWN, T3, 8005.
Over the last 17 years, insiders at Oramed Pharmaceuticals, Inc have traded over $7,377,390 worth of Oramed Pharmaceuticals, Inc stock and bought 881,642 units worth $3,583,418 . The most active insiders traders include Miriam Kidron, Leonard Sank e Nadav Kidron. On average, Oramed Pharmaceuticals, Inc executives and independent directors trade stock every 111 days with the average trade being worth of $97,149. The most recent stock trade was executed by Arie Mayer on 3 April 2023, trading 8,809 units of ORMP stock currently worth $19,556.
oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg
Oramed Pharmaceuticals, Inc executives and other stock owners filed with the SEC include: